Table 4.
Odds ratio for concentric hypertrophy by sST2
| sST2(mg/ml) | Odds ratio(95% confidence interval) | ||||
|---|---|---|---|---|---|
| CH, n% | Non-CH, n% | Crude | Model 1 | Model 2 | |
| Tertile 1 (<12.6) |
21 (13.04%) |
140 (84.96%) |
Reference | Reference | Reference |
| Tertile 2 [12.6–18.7] |
30 (18.52%) |
132 (81.48%) |
1.52 (0.83–2.78) |
1.67 (0.89–3.12) |
1.58 (0.83–2.99) |
| Tertile 3 (≥ 18.8) |
76 (47.50%) |
84 (52.50%) |
6.03 (3.47-10.49) |
6.61 (3.70–11.84) |
5.80 (3.18–10.50) |
| P for trend | P < 0.001 | P < 0.001 | P < 0.001 | ||
| sST2 (per SD increase) | 3.52 (2.60–4.76) |
3.76 (2.71–5.21) |
3.59 (2.57–5.00) |
||
Model 1: adjusted for age, sex, and BMI.
Model 2: multivariate stepwise logistic regression adjusted for age, sex, BMI, diabetes, HbA1c,triglyceride, systolic pressure, pulse pressure, hypertension grade and duration.
Abbreviations: CH, concentric hypertrophy; SD, standard deviation; sST2,soluble stimulating factor 2.